← Back to all trials
Recruiting
NCT07338669
Hamburg Acute Kidney Injury Study (HAKIS)
Conditions: Acute Kidney Injury, Acute Kidney Injury (AKI)
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 1000
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Location: Universitätsklinikum Hamburg-Eppendorf Hamburg
Summary
The Hamburg Acute Kidney Injury Study (HAKIS) is a prospective observational cohort study aimed at investigating the mechanisms, risk factors, and clinical determinants of acute kidney injury (AKI) trajectories and consequences.
Eligibility Criteria
Inclusion Criteria:
* Hospitalized individuals with acute kidney injury (AKI), defined by the 2012 Kidney Disease: Improving Global Outcomes (KDIGO) criteria or hospitalized individuals with acute illness who have not developed AKI (control group)
* Age ≥ 18 years at time of enrollment
* Written informed consent provided by the participant or, in participants lacking decision-making capacity, by a legal representative or healthcare proxy, where available. Participants lacking decision-making capacity without an available legal representative or healthcare proxy may be enrolled if participation is not contrary to their presumed wishes, in accordance with the ethics committee-approved consent procedure. Written informed consent is subsequently sought from the participant upon regaining decision-making capacity or from a legal representative, as applicable.
Exclusion Criteria:
* None
Source: ClinicalTrials.gov (NCT07338669). StuddyBuddy aggregates publicly available trial information.